“Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-Line Clinical Trials”. Journal of Kidney Cancer 11, no. 3 (August 30, 2024): 51–58. Accessed April 17, 2026. https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/352.